Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28826 - 28850 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dactinomycin	Approved Investigational	IL27RA	9466	upregulated	Dactinomycin results in increased expression of IL27RA mRNA	19p13.12	A21863
Dactinomycin	Approved Investigational	ITGA2B	3674	upregulated	Dactinomycin results in increased expression of ITGA2B mRNA	17q21.31	A21863
Dactinomycin	Approved Investigational	KIF1A	547	upregulated	Dactinomycin results in increased expression of KIF1A mRNA	2q37.3	A21863
Dactinomycin	Approved Investigational	KRT80	144501	upregulated	Dactinomycin results in increased expression of KRT80 mRNA	12q13.13	A21863
Dactinomycin	Approved Investigational	LAMC2	3918	upregulated	Dactinomycin results in increased expression of LAMC2 mRNA	1q25.3	A21863
Dactinomycin	Approved Investigational	LGALS7	3963	upregulated	Dactinomycin results in increased expression of LGALS7 mRNA	19q13.13	A21863
Dactinomycin	Approved Investigational	LMNB1	4001	downregulated	Dactinomycin results in decreased expression of LMNB1 mRNA	5q23.2	A21894
Dactinomycin	Approved Investigational	MAP2K4	6416	downregulated	Dactinomycin results in decreased expression of MAP2K4 mRNA	17p12	A21894
Dactinomycin	Approved Investigational	MAP3K7	6885	downregulated	Dactinomycin results in decreased expression of MAP3K7 mRNA	6q15	A21894
Dactinomycin	Approved Investigational	MCL1	4170	downregulated	Dactinomycin results in decreased expression of MCL1 mRNA	1q21.2	A21897
Dactinomycin	Approved Investigational	MLLT11	10962	upregulated	Dactinomycin results in increased expression of MLLT11 mRNA	1q21.3	A21863
Dactinomycin	Approved Investigational	MMP9	4318	downregulated	Dactinomycin results in decreased expression of MMP9 mRNA	20q13.12	A20823
Dactinomycin	Approved Investigational	MYC	4609	downregulated	Dactinomycin results in decreased expression of MYC mRNA	8q24.21	A21894 A21863
Dactinomycin	Approved Investigational	NETO2	81831	upregulated	Dactinomycin results in increased expression of NETO2 mRNA	16q12.1	A21863
Dactinomycin	Approved Investigational	NFKB1	4790	downregulated	Dactinomycin results in decreased expression of NFKB1 mRNA	4q24	A21894
Dactinomycin	Approved Investigational	NTHL1	4913	downregulated	Dactinomycin results in decreased expression of NTHL1 mRNA	16p13.3	A21863
Dactinomycin	Approved Investigational	PLAU	5328	upregulated	Dactinomycin results in increased expression of PLAU mRNA	10q22.2	A21863
Dactinomycin	Approved Investigational	POMT1	10585	upregulated	Dactinomycin results in increased expression of POMT1 mRNA	9q34.13	A21863
Dactinomycin	Approved Investigational	PROCR	10544	upregulated	Dactinomycin results in increased expression of PROCR mRNA	20q11.22	A21863
Dactinomycin	Approved Investigational	RETSAT	54884	upregulated	Dactinomycin results in increased expression of RETSAT mRNA	2p11.2	A21863
Dactinomycin	Approved Investigational	RIPPLY3	53820	upregulated	Dactinomycin results in increased expression of RIPPLY3 mRNA	21q22.13	A21863
Dactinomycin	Approved Investigational	ROS1	6098	upregulated	Dactinomycin results in increased expression of ROS1 mRNA	6q22.1	A21894
Dactinomycin	Approved Investigational	RPL34	6164	upregulated	Dactinomycin results in increased expression of RPL34 mRNA	4q25	A21863
Dactinomycin	Approved Investigational	RRAS	6237	upregulated	Dactinomycin results in increased expression of RRAS mRNA	19q13.33	A21863
Dactinomycin	Approved Investigational	SFN	2810	upregulated	Dactinomycin results in increased expression of SFN mRNA	1p36.11	A21863

Displaying entries 28826 - 28850 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability